首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Clinical Trial Highlights: Targetting Alpha-Synuclein
被引:24
作者
:
McFarthing, Kevin
论文数:
0
引用数:
0
h-index:
0
机构:
Parkinson's Advocate, Innovation Fixer Ltd, Oxford
McFarthing, Kevin
机构
:
[1]
Parkinson's Advocate, Innovation Fixer Ltd, Oxford
[2]
Parkinson's Disease and Movement Disorders Center, Northwestern University, Feinberg School of Medicine, Chicago
来源
:
JOURNAL OF PARKINSONS DISEASE
|
2019年
/ 9卷
/ 01期
关键词
:
D O I
:
10.3233/JPD-189004
中图分类号
:
Q189 [神经科学];
学科分类号
:
071006 ;
摘要
:
[No abstract available]
引用
收藏
页码:5 / 16
页数:12
相关论文
共 2 条
[1]
Pagan F, 2016, J PARKINSONS DIS
[2]
Active immunization therapies for Parkinson's disease and multiple system atrophy
[J].
Schneeberger, Achim
论文数:
0
引用数:
0
h-index:
0
机构:
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
Schneeberger, Achim
;
Tierney, Lanay
论文数:
0
引用数:
0
h-index:
0
机构:
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
Tierney, Lanay
;
Mandler, Markus
论文数:
0
引用数:
0
h-index:
0
机构:
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
Mandler, Markus
.
MOVEMENT DISORDERS,
2016,
31
(02)
:214
-224
←
1
→
共 2 条
[1]
Pagan F, 2016, J PARKINSONS DIS
[2]
Active immunization therapies for Parkinson's disease and multiple system atrophy
[J].
Schneeberger, Achim
论文数:
0
引用数:
0
h-index:
0
机构:
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
Schneeberger, Achim
;
Tierney, Lanay
论文数:
0
引用数:
0
h-index:
0
机构:
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
Tierney, Lanay
;
Mandler, Markus
论文数:
0
引用数:
0
h-index:
0
机构:
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria
Mandler, Markus
.
MOVEMENT DISORDERS,
2016,
31
(02)
:214
-224
←
1
→